Accepted Articles                   Back to the articles list | Back to browse issues page

XML Print

1- Nervous System Stem Cell Research Center, Semnan University of Medical Sciences, Semnan, Iran.
2- Department of Pathology, Semnan University of Medical Sciences, Semnan, Iran.
3- Department of Anatomy, AJA University of Medical Sciences, Tehran, Iran.
Introduction: Parkinson's disease (PD) is the result of the destruction of Dopaminergic neurons in the brain. The aim of this study was to investigate the protective effects of natural antioxidants such as caffeic acid phenethyl ester for the maintenance of these neurons.
Methods: Caffeic acid phenethyl ester (CAPE) is one of the main ingredients of Propolis. Intranasal administration of (1-methyl-4-phenyl-2;3;4;6-tetrahydropyridine) MPTP was used to generate PD model in rats. 2× 106   bone marrow stem cells (BMSCs) were injected from tail vein. Behavioral test, Immunohistochemistry, DiI, cresyl fast violet, TUNEL staining were evaluated, 2 weeks after treatment.
Results: DiI staining method revealed in all treatment groups using stem cells, the cells migrated to the substantia nigra pars compacta after injection. Treatment with CAPE significantly protects dopaminergic neurons from MPTP.  The highest number of tyrosine hydroxylase (TH (positive neurons was seen in group Pre CAPE+PD+Stem cell. The number of TH+ cells in all groups that received CAPE was significant in compared to groups that received the stem cells only (P <0.001). Intranasal administration of MPTP significantly increase the number of apoptotic cells. The lowest number of apoptotic cells was in group Pre CAPE+PD+ Stem cell.
Conclusion: The results showed that the use of CAPE and stem cells in Parkinson's rats caused a significant reduction in the apoptotic cells.
Type of Study: Original | Subject: Cellular and molecular Neuroscience
Received: 2020/07/11 | Accepted: 2020/11/21

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb